Latest news
Loading news…
Phrontline Biopharma
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Shanghai, China Founded 2022 11-50 employees For Profit
Phrontline Biopharma develops biopharmaceutical products to treat cancer through innovative antibody-drug conjugate technology.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 0
Company Info
- Founded
- 2022
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 19
- HQ
- Shanghai, China
- Region
- Asia-Pacific (APAC)
Signals & Scores
- Heat score
- Medium
- Growth score
- High
- Trend (7d)
- 0
- Trend (30d)
- -0.6
- Trend (90d)
- -0.7
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Phrontline Biopharma
Loading news…
FAQs about Phrontline Biopharma
People who checked this page also checked these
Browse the full Acquirezy directory.